SPDR® MSCI EAFE Quality Mix ETFMost RecentCompany & Industry OverviewsOf GSK’s Business Segments, This One Is the Sales LaggardGlaxoSmithKline (GSK) reported a growth of 10.9% in its revenues to 6.5 billion pounds for 2Q16.
Company & Industry OverviewsOf GSK’s Business Segments, This One Is the Sales LaggardGlaxoSmithKline (GSK) reported a growth of 10.9% in its revenues to 6.5 billion pounds for 2Q16.
